Antioxcin4 a New Mitochondriotropic Derivative Based on the Natural Polyphenol Caffeic Acid Reverts Cellular and Mitochondrial Metabolic Defects of Fibroblasts from Idiopathic Parkinson's Disease
                        AuthID
P-00V-2N6
                
    P-00V-2N6
 
    
                    